%20(1).png)
Cutting-edge noninvasive detection.
To increase testing compliance by decreasing discomfort.
About
Us
Background
Currently, there is no immediate diagnosis or combined diagnosis-treatment option for gynecologic malignancies such as cervical, ovarian, and endometrial cancers. This leaves patients vulnerable to greater health risks, including infertility, and the potential of other aggressive types of side effects or risks to quality of life. On a yearly basis there are 7.2 million new cases of cancer of the female reproductive system, of which up to 266,000 result in deaths for cervical cancer.
Our Vision
A microneedle mediated diagnostic patch that detects early onset of cervical cancer, replacing invasive procedures such as the Pap Smear and colposcopies. The digitized medical device, is able to detect novel targets within 30-45 min. - equivalent to a clinical visit. Providing benefits to health professionals for better management of guidelines and improved patient outcomes.
Mission
Curiva is committed to reducing the incidence of cervical cancer by increasing testing compliance through a non-invasive diagnostic patch. Our patient-centric products deliver accurate, same-day results while reducing diagnostic costs for healthcare providers.
EYDIS LIMA,MSc
Founder &
Chief Executive Officer
Entrepreneur | Chemical Engineer
University of Notre Dame
Co - Founder &
Chief Medical Officer
Yale University
Yale Cancer Center
GARY ALTWERGER,MD
PROFESSOR
CHIA CHANG,PHD
Technical Advisor
Director of the Center for Microfluidics and Medical Diagnostics,
University of Notre Dame
ADVISORS
ELIZABETH JENNINGS
Strategy Advisor
Venture Atlas Labs
Startup Advisor
Associate Vice President of Innovation
University of Notre Dame
JAMES THOMPSON,MSc
OUR TEAM
Meet the Curiva team!
ANDRE NOGALES,MBA
Chief Financial Officer
Entrepreneur | Finance
Australian National University
What
We
Offer
diapatch™ screens and detects —
CIN II biomarkers
CIN III biomarkers
HPV biomarkers
Seamless and effortless integration into busy, modern lifestyles, allowing for streamlined, higher quality patient care during the usual women wellness visit or consult with family medicine practitioner, gynecologist, or gynecologic oncologist.
Accurate, quick,
and noninvasive diagnosis
diapatch™ CER — designed with patients that have had a series of abnormal Pap Smears in mind, it provides an additional tool prior to detect and monitor disease burden prior to colposcopies.
diapatch™ HPV — supports patients wanting a non-invasive, lower anxiety option for yearly well women's exams. Not only capturing the screening market but also facilitating screening of HPV at earlier ages.
Why
Us?
Faster, more accurate diagnosis
Non-invasive approach for easier workflow and patient care
Same-day results for appropriate patient triaging, follow-up procedures, and treatment options
Contact
Us
Our Office
MATTER
222 W Merchandise Mart Plaza #1230, Chicago, IL 60654
Our Labs
Innovation Park
1400 East Angela Blvd.
South Bend, IN 46617
Our Email
Our Phone No.
574-400-5136